AccuStem Sciences, Inc. Announces Chairman Purchase of Shares Press Release AccuStem Sciences, Inc. Announces Chairman Purchase of Shares By accustem|2022-06-08T15:40:00-07:00April 28, 2022|Press Release|
AccuStem Announces DTC Eligibility Press Release AccuStem Announces DTC Eligibility By accustem|2022-06-09T13:35:05-07:00April 14, 2022|Press Release|
AccuStem Announces Private Placement of Common Stock Press Release AccuStem Announces Private Placement of Common Stock By accustem|2022-06-08T15:45:56-07:00April 5, 2022|Press Release|
AccuStem Sciences, Inc. Announces DTC Eligibility Press Release AccuStem Sciences, Inc. Announces DTC Eligibility By accustem|2022-06-08T21:24:30-07:00March 23, 2022|Press Release|
AccuStem Sciences, Inc. Appoints New Executive Leadership Team Press Release AccuStem Sciences, Inc. Appoints New Executive Leadership Team By accustem|2022-06-09T13:34:47-07:00March 4, 2022|Press Release|
AccuStem’s StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort Press Release AccuStem’s StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort By accustem|2022-06-08T21:43:08-07:00March 1, 2022|Press Release|
Scheme of Arrangement Effective Press Release Scheme of Arrangement Effective By accustem|2022-06-08T22:06:22-07:00December 1, 2021|Press Release|
Court Sanctions the Scheme of Arrangement Press Release Court Sanctions the Scheme of Arrangement By accustem|2022-06-08T21:56:12-07:00November 26, 2021|Press Release|
Results of Shareholder Meetings Press Release Results of Shareholder Meetings By accustem|2022-06-08T22:25:04-07:00November 25, 2021|Press Release|
Accustem Scheme Document Press Release Accustem Scheme Document By accustem|2022-06-08T22:18:08-07:00November 20, 2021|Press Release|
